Ayr Strategies Granted Final License Approvals for Cultivation Expansion; Resumes Vape Sales in Massachusetts
19 Diciembre 2019 - 1:30PM
Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr” or the
“Company”), a vertically-integrated cannabis multi-state operator
(MSO) with a presence in the western and eastern U.S., has received
final license approval from the Cannabis Control Commission (“CCC”)
to grow cannabis in its recently completed cultivation facility, as
disclosed by the CCC today. This is the Company’s second
cultivation facility in Milford, Massachusetts.
Ayr completed its expansion plans in November to create one of
the largest cultivation facilities in Massachusetts, and was solely
awaiting approval from the CCC to grow cannabis in the new space.
Ayr sells its products to both retail and wholesale customers
throughout Massachusetts, with its products currently available at
55% of dispensaries in the state.
“Massachusetts continues to be one of the strongest growth
opportunities for recreational cannabis across the U.S.,” said
Jonathan Sandelman, CEO of Ayr. “This license approval from the CCC
comes at a critical time as we can now more than double our
cultivation and manufacturing capacity to meet our growing
wholesale and retail demand. We expect to complete our first
harvest from the new facility in Q1 2020, with flower sales from
the new facility commencing in Q2.”
First to Resume Vape Sales Following Lift of Temporary
Ban
Additionally, Ayr will be the first licensed cannabis company in
the state to resume vape cartridge sales for its dispensaries and
at the wholesale level beginning today, December 19, 2019.
“The health and well-being of our customers has always been the
number one focus of our organization,” Sandelman added. “Following
the CCC’s December 12, 2019 announcement that it would lift the
temporary ban on sales of cannabis vaping products, we submitted
our products for testing, which has confirmed that they meet the
CCC’s newly revised safety standards. We are pleased to resume vape
sales earlier than our prior expectation of Q1 2020, and look
forward to once again providing the highest quality products
available to the medical and adult-use marketplaces.”
Ayr’s ongoing internal safety tests, in addition to independent,
state-certified lab analyses, validate that the contents and
hardware used in its vape cartridges meet the highest-quality
standards. In accordance with Massachusetts state law, all products
must pass testing to confirm absence of contaminants, residual
solvents, heavy metals or additives such as Vitamin-E-Acetate are
present before being sold.
About Ayr Strategies Inc.Ayr is a vertically
integrated multi-state operator in the U.S. cannabis sector, with
an initial anchor portfolio in Massachusetts and Nevada. Through
its operating companies, Ayr is a leading cultivator, manufacturer
and retailer of cannabis products and branded cannabis packaged
goods. Ayr seeks to create regional clusters in core
geographies for future expansion, while pursuing strong organic
growth within its existing portfolio. For more information, please
visit www.ayrstrategies.com.
Forward-Looking StatementsCertain information
contained in this news release may be forward-looking statements
within the meaning of applicable securities laws. Forward-looking
statements are often, but not always identified by the use of words
such as “target”, “expect”, “anticipate”, “believe”, “foresee”,
“could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “will”,
“may” and “should” and similar expressions or words suggesting
future outcomes. This news release includes forward-looking
information and statements pertaining to, among other things, Ayr’s
future growth plans. Numerous risks and uncertainties could cause
the actual events and results to differ materially from the
estimates, beliefs and assumptions expressed or implied in the
forward-looking statements, including, but not limited to:
anticipated strategic, operational and competitive benefits may not
be realized; events or series of events may cause business
interruptions; required regulatory approvals may not be obtained;
acquisitions may not be able to be completed on satisfactory terms
or at all; and Ayr may not be able to raise additional capital.
Among other things, Ayr has assumed that its businesses will
operate as anticipated, that it will be able to complete
acquisitions on reasonable terms, and that all required regulatory
approvals will be obtained on satisfactory terms and within
expected time frames.
Company Contact:Jennifer Drake, COOT: (212)
299-7606
Investor Relations Contact:Sean Mansouri, CFA
or Cody Slach Gateway Investor Relations T: (949) 574-3860
Email: ayr@gatewayir.com
Ayr Wellness (CSE:AYR.A)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Ayr Wellness (CSE:AYR.A)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025